Pharmacological Neuroenhancement
| dc.contributor.author | Schilling, Ralph | |
| dc.contributor.author | Hoebel, Jens | |
| dc.contributor.author | Müters, Stephan | |
| dc.contributor.author | Lange, Cornelia | |
| dc.date.accessioned | 2018-05-07T21:30:04Z | |
| dc.date.available | 2018-05-07T21:30:04Z | |
| dc.date.created | 2014-02-13 | |
| dc.date.issued | 2012-06-26 | none |
| dc.identifier.other | http://edoc.rki.de/series/gbe-kompakt/3-3/PDF/3_de.pdf | |
| dc.identifier.uri | http://edoc.rki.de/176904/3118 | |
| dc.description.abstract | June, 26th is International Day against Drug Abuse and Illicit Trafficking. Neuroenhancement is therefore the focus of this issue of GBE kompakt. Results of KOLIBRI, a study by Robert Koch-Institute, are presented which show who is doing cognitive enhancement and why. The results are discussed in context of other studies, but show similar outcomes. | eng |
| dc.language.iso | ger | |
| dc.publisher | Robert Koch-Institut | |
| dc.subject | GEDA | eng |
| dc.subject | prevalence | eng |
| dc.subject | Neuroenhancement | eng |
| dc.subject | doping | eng |
| dc.subject | KOLIBRI | eng |
| dc.subject.ddc | 610 Medizin | |
| dc.title | Pharmacological Neuroenhancement | |
| dc.type | report | |
| dc.identifier.urn | urn:nbn:de:0257-10038663 | |
| dc.identifier.doi | http://dx.doi.org/10.25646/3043 | |
| local.edoc.container-title | GBE kompakt | |
| local.edoc.container-title | GBE kompakt | |
| local.edoc.pages | 7 | |
| local.edoc.type-name | Berichte und sonstige Texte | |
| local.edoc.container-volume | 3 | |
| local.edoc.container-issue | 3 | |
| local.edoc.container-year | 2012 |